As of 2025-09-17, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (192.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -958.1%.
The range of the Relative Valuation is (187.87) - (197.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 13.5x | 13.1x |
| Forward P/E multiples | 12.7x - 13.4x | 13.0x |
| Fair Price | (187.87) - (197.31) | (192.81) |
| Upside | -936.1% - -978.1% | -958.1% |
| Date | P/E |